• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Immutep Limited - American Depositary Shares (NQ:IMMP)

    0.3826 -0.0096 (-2.45%)
    Streaming Delayed Price Updated: 3:35 PM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Immutep Limited - American Depositary Shares

    < Previous 1 2 3 Next >
    On Thursday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    These stocks are moving in today's session ↗
    Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    Which stocks are most active on Wednesday? ↗
    These stocks are making the most noise in today's session. Stay tuned for the latest updates! 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    Here are the top movers in Wednesday's session. ↗
    Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    These stocks are moving in today's pre-market session ↗
    Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    Topics Artificial Intelligence
    On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo ↗
    Immutep's efti combo with Keytruda and chemo shows a 60.8% response rate in lung cancer trial, with strong efficacy across PD-L1 expression levels. 
    Via Benzinga
    News headline image
    Unusual volume stocks in Wednesday's session ↗
    Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session. 
    Via Chartmill
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    In today's session, these stocks are experiencing unusual volume. 
    Via Chartmill
    News headline image
    Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial ↗
    Immutep's INSIGHT-003 Phase 1 trial reports promising survival data for 1L NSCLC treatment using eftilagimod alpha, Keytruda, and chemotherapy. 
    Via Benzinga
    News headline image
    Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
     
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday 
    Via InvestorPlace
    News headline image
    Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars ↗
    Immutep announces results from Cohort B of the TACTI-003 Phase 2b trial. The combination of eftilagimod alfa and Merck's Keytruda shows a 35.5% ORR and 58.1% DCR in PD-L1 negative head and neck cancer... 
    Via Benzinga
    News headline image
    Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
    Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning! 
    Via InvestorPlace
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? ↗
    Immutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line treatment of HNSCC patients without PD-L1 expression. Final data expected in H1 CY2024. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Cancer Focused Immutep's Stock Soars On Tuesday - Here's Why ↗
    Immutep releases promising safety and efficacy data for 90mg eftilagimod alpha combined with paclitaxel in HR+/HER2- metastatic breast cancer. No serious adverse events were reported, and a 50% overall... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.